INBS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Intelligent Bio Solutions Inc (INBS) is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. Despite some positive developments like securing a European patent and revenue growth, the company's financials show significant losses, declining EPS, and gross margin deterioration. Technical indicators are mixed, with bearish moving averages and neutral RSI. Additionally, there are no strong trading signals or significant trading trends to support immediate action.
The MACD is positive and expanding, indicating potential upward momentum. However, the RSI is neutral at 28.126, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 3.638, with key resistance at 4.02 and support at 3.256.
The company secured its eighth European patent, enhancing its fingerprint sweat drug testing technology. Revenue increased by 47.62% YoY in Q2 2026.
Net income remains negative at -$2,677,590, and EPS dropped significantly by -43.15% YoY. Gross margin declined sharply to 19.83%, down -246.78% YoY. No significant trading trends or signals from hedge funds, insiders, or Congress.
In Q2 2026, revenue increased by 47.62% YoY to $896,774. However, net income remains negative at -$2,677,590, despite a 19.03% improvement YoY. EPS dropped by -43.15% YoY to -2.82, and gross margin declined significantly to 19.83%, down -246.78%.
No analyst rating or price target changes available for this stock.
